News and Trends 4 Jan 2023Aditxt forms Adimune to focus on immune modulation therapies Aditxt, Inc., a biotech innovation company developing and commercializing technologies with a focus on monitoring and modulating the immune system,… January 4, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email